Morning Movers: Mylan Leaps on Generic EpiPen Launch; Regeneron Gains on Trial Data

Stocks are little changed this morning following the surprisingly hawkish statements that emanated from Fed speakers at Jackson Hole on Friday. Reuters S&P 500 futures have advanced 0.02%, while Dow Jones Industrial Average futures have dipped 0.01%. Nasdaq Composite futures are off 0.01%. Mylan (MYL) has gained 2.3% to $44 after announcing its own generic version […]